{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:09:43Z","timestamp":1762124983935,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.chest.2025.04.042","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:11:58Z","timestamp":1759914718000},"page":"e111-e113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor"],"prefix":"10.1016","volume":"168","author":[{"given":"Yue-jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0517-3352","authenticated-orcid":false,"given":"Wan-jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2025.04.042_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1378\/chest.105.6.1826","article-title":"Respiratory dyskinesia: an underrecognized phenomenon","volume":"105","author":"Rich","year":"1994","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2025.04.042_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40265-018-0874-x","article-title":"Treatment of tardive dyskinesia: a general overview with focus on the vesicular monoamine transporter 2 inhibitors","volume":"78","author":"Niemann","year":"2018","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.chest.2025.04.042_bib3","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis","volume":"78","author":"Carbon","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.chest.2025.04.042_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.149.8.1081","article-title":"Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong","volume":"149","author":"Chiu","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.chest.2025.04.042_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/NDT.S310605","article-title":"Assessment of the impact of tardive dyskinesia in clinical practice: consensus panel recommendations","volume":"17","author":"Jackson","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"10.1016\/j.chest.2025.04.042_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2020.07.006","article-title":"Hyperventilation syndrome: why is it regularly overlooked?","volume":"134","author":"Tavel","year":"2021","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.chest.2025.04.042_bib7","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.NU18041BR4C","article-title":"Treatment strategies for tardive dyskinesia","volume":"81","author":"Kremens","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"19","key":"10.1016\/j.chest.2025.04.042_bib8","first-page":"1942","article-title":"Tardive dyskinesia drug approved","volume":"317","author":"Voelker","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.chest.2025.04.042_bib9","first-page":"1317","article-title":"Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia","volume":"90","author":"Fernandez","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.chest.2025.04.042_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0706743719828968","article-title":"Treatment recommendations for tardive dyskinesia","volume":"64","author":"Ricciardi","year":"2019","journal-title":"Can J Psychiatry"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225005781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225005781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:06:00Z","timestamp":1762124760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369225005781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0012369225005781"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.04.042","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}